BIO-RAD LABORATORIES, INC.
BIO· NYSE, NYSE· Laboratory Analytical Instruments
- Market cap
- –
- P/FCF
- –
- EV/Sales
- –
- FCF margin
- 14.5%
- ROIC, 5 yr avg
- –
- Revenue, 5 yr CAGR
- +0.3%
We record prices for the companies we cover; BIO is not one of them yet.
Company statistics
Profile · FY2025
- Market cap
- –
- Enterprise value
- –
- Diluted shares
- 27.3M
- Revenue
- $2.6B
- Free cash flow
- $374.6M
- Owner earnings
- $316.6M
Valuation · FY2025
- P/E
- –
- P/FCF
- –
- P/Owner earnings
- –
- EV/Sales
- –
- EV/FCF
- –
- P/B
- –
Margins · FY2025
- Gross
- 51.9%
- Operating
- 1.8%
- Net
- 29.4%
- Free cash flow
- 14.5%
- Owner earnings
- 12.3%
- Stock pay
- 2.2%
Returns
- ROIC, FY2025
- 0.5%
- ROIC, 5 yr avg
- –
- ROE, FY2025
- 10.2%
- ROE, 5 yr avg
- -6.4%
Growth (CAGR)
- Revenue, 3 yr
- -2.7%
- Revenue, 5 yr
- 0.3%
- Revenue, 9 yr
- 2.5%
- Diluted EPS, 3 yr
- –
- Diluted EPS, 5 yr
- -26.1%
- Diluted EPS, 9 yr
- 46.8%
- Free cash flow, 3 yr
- 66.2%
- Free cash flow, 5 yr
- -4.7%
- Free cash flow, 9 yr
- 19.6%
Financial health · FY2025
- Cash and investments
- $1.5B
- Total debt
- $1.2B
- Net cash
- $339.0M
- Debt/Equity
- 0.2x
- Debt/FCF
- 3.2x
Shareholder returns · FY2025
- Dividend yield
- –
- Payout ratio
- –
- Buyback yield
- –
- Shareholder yield
- –
- Share count, 5 yr
- -2.0%
Financials: ten years from the 10-Ks
Revenue
$2.6B
+2.5% a year over 9 years
FY2016FY2025
Margins
Gross51.9%Operating1.8%Net29.4%
FY2025
FY2016FY2025
Free cash flow and owner earnings
Free cash flow$374.6MOwner earnings$316.6M
Free cash flow +19.6% a year
FY2016FY2025
Diluted shares
27.3M
-8.0% over 9 years, net buybacks
FY2016FY2025
Return on invested capital
0.5%
FY2025
FY2016FY2025
Net cash
$339.0M
$339.0M more cash than debt
FY2016FY2025
Every figure, year by year
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| The business | ||||||||||
| Revenue | $2.1B | $2.2B | $2.3B | $2.3B | $2.5B | $2.9B | $2.8B | $2.7B | $2.6B | $2.6B |
| Revenue growth | 2.4% | 4.4% | 6.0% | 1.0% | 10.1% | 14.8% | -4.1% | -4.7% | -3.9% | 0.7% |
| Gross margin | 55.0% | 55.0% | 53.4% | 54.4% | 56.5% | 56.1% | 55.9% | 53.4% | 53.7% | 51.9% |
| Operating margin | 2.7% | 5.5% | -4.5% | 9.9% | 16.6% | 17.1% | 17.2% | 12.6% | 10.5% | 1.8% |
| Net income | $26.0M | $122.2M | $365.6M | $1.8B | $3.8B | $4.3B | -$3.6B | -$637.3M | -$1.8B | $759.9M |
| Net margin | 1.3% | 5.7% | 16.0% | 76.1% | 149.8% | 145.6% | -129.5% | -23.9% | -71.9% | 29.4% |
| Diluted EPS | $0.88 | $4.07 | $12.10 | $58.27 | $126.47 | $140.83 | $-121.79 | $-21.82 | $-65.36 | $27.85 |
| Return on invested capital? | – | – | – | – | – | – | – | – | – | 0.5% |
| Cash | ||||||||||
| Operating cash flow | $216.1M | $104.1M | $285.5M | $457.9M | $585.0M | $669.5M | $194.4M | $374.9M | $455.2M | $532.2M |
| Capital expenditure | $141.4M | $111.3M | $129.8M | $98.5M | $108.6M | $133.7M | $112.8M | $156.7M | $165.6M | $157.6M |
| Free cash flow | $74.6M | -$7.2M | $155.7M | $359.4M | $476.4M | $535.7M | $81.6M | $218.2M | $289.6M | $374.6M |
| Stock-based compensation | $19.7M | $23.4M | $27.8M | $35.6M | $41.6M | $51.2M | $60.9M | $61.3M | $62.3M | $58.0M |
| Owner earnings? | $54.9M | -$30.6M | $127.9M | $323.8M | $434.8M | $484.5M | $20.7M | $156.9M | $227.3M | $316.6M |
| Free cash flow per share | $2.52 | $-0.24 | $5.15 | $11.91 | $15.80 | $17.73 | $2.74 | $7.47 | $10.26 | $13.73 |
| Capital allocation | ||||||||||
| Dividends paid | – | – | – | – | – | – | – | – | – | – |
| Share repurchases | $0 | $2.9M | $48.9M | $28.0M | $100.0M | $50.0M | $215.7M | $428.7M | $203.6M | $295.5M |
| Diluted shares | 29.6M | 30.0M | 30.2M | 30.2M | 30.2M | 30.2M | 29.8M | 29.2M | 28.2M | 27.3M |
| Share count change? | 0.8% | 1.3% | 0.6% | -0.1% | -0.1% | 0.2% | -1.4% | -1.9% | -3.4% | -3.3% |
| Balance sheet | ||||||||||
| Cash and equivalents | $456.3M | $383.8M | $431.5M | $660.7M | $662.2M | $470.8M | $434.2M | $403.8M | $488.1M | $529.8M |
| Short-term investments | $383.2M | $371.2M | $413.3M | $454.0M | $328.9M | $399.1M | $1.4B | $1.2B | $1.2B | $1.0B |
| Total debt | – | – | – | – | – | – | $1.2B | $1.2B | $1.2B | $1.2B |
| Net debt | – | – | – | – | – | – | -$593.0M | -$408.0M | -$464.1M | -$339.0M |
| Shareholders' equity | $2.6B | $2.9B | $4.0B | $5.8B | $9.9B | $13.7B | $9.6B | $8.7B | $6.6B | $7.5B |
Latest filings
| 2026-08-04 | 10-Q | Quarterly report |
| 2026-08-04 | 8-K | Earnings release |
| 2026-04-30 | 10-Q | Quarterly report |
| 2026-04-30 | 8-K | Earnings release |
| 2026-03-25 | DEF 14A | Proxy statement |
| 2026-02-13 | 10-K | Annual report |
| 2026-02-12 | 8-K | Earnings release |
| 2025-10-29 | 10-Q | Quarterly report |
| 2025-10-29 | 8-K | Earnings release |
| 2025-07-31 | 10-Q | Quarterly report |
More from our coverage
- MSFTPlatforms8.4MicrosoftThe most entrenched software franchise in the enterprise, now spending its cash flow on AI capacity; a great business we would own with a margin of safety, not at any price.Base value $410.29
- NVDAAI infrastructure8.4NVIDIAThe best business in technology at the top of its cycle: the moat is CUDA as much as silicon, but today's margins are a peak, not a floor.Base value $104.32
- AAPLHardware7.6AppleOne of the highest-quality businesses in the world growing in the low single digits; the price usually assumes more growth than the numbers show.Base value $134.27
- GOOGLPlatforms7.4AlphabetSearch pays for everything, and AI is both its biggest threat and its biggest opportunity; the price has to allow for search being worth less than it was.Base value $209.60
- NOWSoftware7.4ServiceNowA rare enterprise platform still growing above 20% with high retention; the free cash flow is real but stock pay takes a large share of it.Base value $189.13
- ADBESoftware7.4AdobeSuperb margins and a shrinking share count, priced for decline; the question is whether AI makes Adobe's tools more valuable or makes them unnecessary.Base value $449.35
